Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells - PubMed (original) (raw)

D A Zajchowski et al. Proc Natl Acad Sci U S A. 1990 Mar.

Abstract

Somatic cell hybrids between MCF-7 human breast cancer cells and normal immortalized human mammary epithelial cells have been obtained by polyethylene glycol-mediated cell fusion. The hybrid cells are suppressed in their ability to form tumors in nude mice, as well as in traits specific to the tumorigenic MCF-7 parent: growth factor independence, tumor necrosis factor sensitivity, and pS2 gene expression. In addition, they display other characteristics of the "normal" parent, including increased expression relative to the MCF-7 cells of the genes for the extracellular matrix component fibronectin, the intermediate filament keratin 5, and the angiogenesis inhibitor thrombospondin. The levels of keratins 8 and 18 also resemble those of the nontumorigenic parent. These results provide evidence for the existence of tumor suppressor gene products in immortal mammary epithelial cells. We propose a characteristic "suppressed" tumor cell phenotype, which encompasses altered cytoarchitecture, angiogenesis capabilities, and growth factor requirements.

PubMed Disclaimer

References

    1. Endocrinology. 1987 Nov;121(5):1759-65 - PubMed
    1. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6563-6 - PubMed
    1. Cancer Res. 1987 Jan 1;47(1):145-9 - PubMed
    1. Breast Cancer Res Treat. 1986;8(1):29-34 - PubMed
    1. Science. 1985 Nov 22;230(4728):943-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources